Merus Labs International Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

MSLI 1.40 -0.12 (-7.89%)
price chart
Merus Labs International Inc. Announces Completion of $7 Million Financing ...
14, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that, further to its news release dated July 4, 2014, the Company has today completed the financing acquisition transaction with Dacha ...
Related articles »  
Merus Labs International Inc. Completes $20 Million Bought Deal Financing
Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the "Underwriters") co-led by Cormark ...
Related articles »  
Merus Labs International Inc. Announces Acquisition of Sintrom(R)
8, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that one of its wholly owned subsidiaries has acquired from Novartis AG ("Novartis"), in certain European countries, the rights to ...
Merus Labs Acquire Sintrom from Novartis  Pharmaceutical Processing
Related articles »  
Merus Labs International Inc. Announces Aggregate $21 Million Financing ...
TORONTO, ONTARIO--(Marketwired - June 10, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has entered into a private placement subscription agreement to ...
Related articles »  
Closing Bell Reports: Merus Labs International Inc. (MSLI), The St. Joe ...
Merus Labs International Inc. (MSLI) of the Healthcare sector lost -4.49%, a change from open of -1.9700% ($-0.07 per share) at the close of the normal trading day Friday, November 7th, 2014 with a volume of 16005 shares.
EmergingGrowth.com looks at Merus Labs International Inc. After Better than ...
May 28, 2013 (ACCESSWIRE via COMTEX) -- Merus Labs International Inc. MSLI, +2.16% (MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.
Related articles »  
Merus Labs International Inc. Announces Conversion of $10 Million Convertible ...
In aggregate, the Company will issue 6,677,918 common shares to convert the outstanding $10 million principal amount plus accrued but unpaid interest.
Related articles »  
Merus Labs International Inc. Announces $22.1 Million Bought Deal Financing
TORONTO, June 11, 2014 /CNW/ - Merus Labs International Inc. ("the Company" or "Merus") [TSX: MSL] [NASDAQ: MSLI] is pleased to announce that it has entered into an agreement with a syndicate of investment dealers co-led by Canaccord Genuity Corp ...
Merus Labs rockets 20% on $27 mln bought deal offering  Proactive Investors USA & Canada
Low share price no obstacle as Merus Labs, Madalena Energy raise equity  Financial Post
Related articles »  
Merus Labs International Inc. Announces Closing of $10 Million Preferred Share ...
TORONTO, ONTARIO--(Marketwired - July 11, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that the Company has completed its previously announced private placement issuance of ...
Related articles »  
Merus Labs International Inc. Announces Board Appointment
TORONTO, ONTARIO--(Marketwired - May 27, 2014) - Merus Labs International Inc. ("Merus" or the "Company") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce today that it has appointed Theresa Firestone to its board of directors.
Related articles »